drugset / Trial / NCT03617016

Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia

NCT03617016

Phase 4 Completed 160 enrolled Xian-Janssen Pharmaceutical Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

The main purpose of the study is to assess the efficacy of domperidone in treatment of functional dyspepsia (FD) in Chinese participants and identify sub-populations (subtype of the disease) who are sensitive to domperidone treatment.

Timeline

Start
2018-08-27
Primary completion
2020-07-31
Completion
2020-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown 10 mg Oral

Indications